Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine.
Cells of embryos of the high leukemic mouse strain AKR can be grown in culture as virus-negative cell lines. However, these lines and clonal sublines uniformly have the capacity to initiate synthesis of murine leukemia virus. Exposure of the cells to 5-iododeoxyuridine or 5-bromodeoxyuridine induced synthesis of virus in as high as 0.1 to 0.5 percent of the cells; many of the cells were producing virus as soon as 3 days after initiation of treatment. Induction of virus by these drugs is several orders of magnitude greater than that obtained with any other treatment tested. These studies indicate that the full genome of murine leukemia virus is present in an unexpressed form in all AKR cells and provide a potentially powerful technique for activating leukemia virus genomes in other cell systems.
D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002460:Cell Line; D002478:Cells, Cultured; D005455:Fluorescent Antibody Technique; D007065:Idoxuridine / Q000494:pharmacology*; D009052:Leukemia Virus, Murine / Q000254:growth & development* / Q000472:pathogenicity; D051379:Mice; D014466:Ultraviolet Rays; D014779:Virus Replication / Q000187:drug effects
D000956:Antigens, Viral; D001973:Bromodeoxyuridine; D007065:Idoxuridine